Le Registre des lobbyistes
Version 5 de 8 (1998-08-11 à 1999-03-11) a été soumis avant l'entrée en vigueur de la Loi sur le lobbying, le 2 juillet 2008. En raison d'exigences de renseignements différents à ce moment-là, l'enregistrement est présenté sous le format suivant.
| Organisation : |
CANADIAN SOCIETY OF HOSPITAL PHARMACISTS (CSHP)
350 - 1145 HUNT CLUB ROAD OTTAWA, ON K1V 0Y3 Canada |
| Numéro de téléphone : | 613-736-9733 |
| Numéro de fax : | 613-736-5660 |
| Nom et poste de l'agent responsable pendant la période de cet enregistrement : | WILLIAM J LESLIE, EXECUTIVE DIRECTOR |
| Description des activités de l'organisation : | THE CANADIAN SOCIETY OF HOSPITAL PHARMACISTS (CSHP) IS THE NATIONAL VOLUNTARY ORGANIZATION OF PHARMACISTS WHO SHARE AN INTEREST IN PHARMACY PRACTICE IN HOSPITALS AND RELATED HEALTH CARE SETTINGS.CSHP'S VISION IS: COMMITTED CAREGIVERS.... CHALLENGING EACH OTHER THROUGH SHARING & EDUCATION , LEADING PHARMACY THROUGH STANDARDS & INNOVATION. THE RELATED VISION OBJECTIVES ARE:1- ENCOURAGE MEMBERS TO DEVELOP & SHARE INNOVATIVE DIRECT PATIENT CARE PRACTIVE MODELS & EXPERIENCE2- PROMOTE THE DIRECT PATIENT CARE ROLE OF THE PHARMACIST TO: MEMBERS, PATIENTS, EDUCATORS, STUDENTS, GOV'T, HEALTH CARE PROVIDERS & ORGANIZATIONS3- PROVIDE ACCESSIBLE EDUCATION TO ASSIST MEMBERS IN ACHIEVING A DIRECT PATIENT CARE ROLE |
| Membres ou types de membres de l'organisation. : | 1- ACTIVE MEMBERS ARE PHARMACISTS LICENSED OR REGISTERED WITH A PHARMACY REGULATORY BODY IN CANADA OR PERSONS WITH A PROFESSIONAL DEGREE IN PHARMACY2- HONORARY MEMBERS - ELECTED BY A 2/3 VOTE OF THE COUNCIL OF THE SOCIETY3- STUDENT MEMBERS ARE PERSONS ENROLLED IN A BACCALAUREATE DEGREE PROGRAM IN PHARMACY4- SUPPORTING MEMBERS ARE PERSONS NOT ELIGIBLE FOR OTHER MEMBERSHIP CATEGORIES5- CORPORATE MEMBERS ARE CORPORATIONS WHO SUPPORT THE OBJECTIVES OF AND PAY FEES TO THE SOCIETY |
| L'organisation a-t-elle été financée en tout ou en partie par une institution gouvernementale domestique ou étrangère au cours du dernier exercice financier complet? | Non |
| Nom : | WILLIAM LESLIE |
| Titre du poste : | EXECUTIVE DIRECTOR |
| Charges publiques occupées : | S/O. La divulgation de cette information n'était pas une exigence avant le 20 juin 2005. |
| Institutions fédérales qui ont été ou seront consultées au cours de l'engagement. : | Conseil d'examen du prix des médicaments brevetés (CEPMB), DRUGS DIRECTORATE, HEALTH PROTECTION BRANCH, Environnement Canada, Industrie Canada, Santé Canada (SC) |
|
Techniques de communication déjà utilisées ou qui seront utilisées au cours de l'engagement :
|
Appels téléphoniques, Communications informelles, Communications écrites, en format papier ou électronique, Réunions |
| Objet : Sujets de préoccupation : | Santé |
| Objets poursuivis : Renseignements rétrospectifs : | . REPRESENT CSHP ON TPP (THERAPEUTIC PRODUCTS PROGRAMME) ADVISORY PANEL ON ELECTRONIC TRANSFER OF INFORMATION (APETI). REPRESENT CSHP AT NATIONAL PHARMACARE AND NATIONAL HOMECARE CONFERENCES. CONTINUED WORK WITH TPP ON HOSPITAL COMPOUNDING VS. MANUFACTURING INITIATIVE. PMPRB MANDATE REVIEW (ALSO COMMENTED ON RULES OF OPERATION DISCUSSION PAPER).AS MEMBER OF "NATIONAL PHARMACY COALITION ON MANAGED CARE", DISCUSSIONS ON NIHB ISSUES. RESPONSES TO REQUESTS FOR COMMENT: TPP - PUBLICATION OF SPECIAL ACCESS PRODUCT INFORMATION; GMP REQUIREMENTS FOR SCHEDULE "D" DRUGS; AFFIRMATION OF CSHP POSITION ON DIRECT TO CONSUMER ADVERTISING; REPEAL OF DIVISON 20 REGULATIONS TO FOOD & DRUG ACT; SCHEDULE A AMENDMENTS REGARDING HEPATITIS; CHANGES TO CONTROLLED DRUG AND SUBSTANCES ACT; MEDICAL DEVICE COST RECOVERY REGULATIONS; RX TO OTC SWITCH OF ACETAMINOPHEN 650 MG SR; COMMENT ON DRUG PRODUCT MONOGRAPH TEMPLATE; PRODUCT LICENSING FRAMEWORK AND BIOAVAILABILITY STUDIES. BILL S-13 TOBACCO INDUSTRY RESPONSIBILITY ACT |
| Objets poursuivis : Renseignements prospectifs : | . CONTINUED REPRESENTATION ON TPP'S APETI. CONTINUED WORK WITH TPP ON HOSPITAL COMPOUNDING VS. MANUFACTURING. RESPONSES TO HEALTH RELATED ISSUES PUBLISHED IN CANADA GAZETTE. RESPONSE TO TPP REQUESTS FOR COMMENT & PARTICIPATION IN CONSULTATIVE WORKSHOPS. PARTICIPATION IN INITIATIVES WHICH MAY ARISE RELATED TO NATIONAL PHARMACARE & HOMECARE PROGRAMMES |